Though, OX40 expression is overall associated with anti-tumour immunity, in HCC it has also been correlated to more aggressive disease (i.e., displaying increased alpha feto-protein (AFP) and vascular invasion) and to impaired survival (125). Here, AFP is linked to hepatocellular carcinoma.